Science Based Satire: We Need Randomized Controlled Clinical Trials of SARS-CoV-2

Somewhere on the internet, a brave soul has stood up and demanded what they believe is the highest form of truth:
a randomized controlled clinical trial (RCT) proving that SARS-CoV-2 causes COVID-19. Not “strong evidence.”
Not “overwhelming convergence of lab, clinical, and population data.” No. A pristine, double-blind, placebo-controlled,
peer-reviewed, gold-plated RCT where half the participants get a virus and half get… what, exactly? A gentle spritz of distilled water and good vibes?

If that sounds a little off, congratulations: you have functioning ethics, a basic understanding of how clinical research works,
and a healthy suspicion of anyone who says “Just randomize it!” the way someone else might say “Just microwave it!”
(Spoiler: not everything should go in the microwave. Not everything should go in an RCT either.)

This is a science-based satire about a very real misunderstanding: the idea that if something hasn’t been proven by an RCT,
it isn’t real. In evidence-based medicine, RCTs are powerful toolsbut they’re tools, not universal truth machines.
And when you misuse them, you don’t get better science. You get nonsense with confidence.

What People Mean When They Chant “RCT! RCT!”

A randomized clinical trial is a study where participants are assigned by chance to different groups to compare interventions.
Randomization helps reduce bias by making groups more similar at baseline, so differences in outcomes are more likely due to the intervention.
In plain English: if you want to know whether a treatment works, randomization can help you avoid fooling yourself.

That “intervention” part matters. RCTs are designed to test treatments, preventions, or strategiesthings you can ethically and practically assign.
You can randomize a vaccine versus placebo (when ethically appropriate). You can randomize one antiviral versus another.
You can randomize dosing schedules. You can randomize reminder texts for follow-up visits.
You cannot responsibly randomize “exposure to a potentially dangerous pathogen” in the way your imaginary comment section demands,
because the entire point of public health is to prevent avoidable harm, not allocate it like raffle tickets.

The “Gold Standard” Myth (and Why It Needs a Seatbelt)

People call RCTs the “gold standard” because, for certain questions, they provide strong causal evidence.
But the “gold standard” phrase has been stretched so far it’s now basically taffy.
If you treat RCTs as the only acceptable evidence, you end up dismissing everything elseincluding the evidence that tells you when an RCT would be unethical.

A better way to think about it: evidence is a toolbox. RCTs are a very good wrench. They are not a universal screwdriver.
And they’re definitely not a magical wand you wave at reality while shouting, “BE RANDOMIZED!”

So… Why Not Run an RCT of the Virus Itself?

The satirical version of this idea is simple: “Let’s prove SARS-CoV-2 causes COVID-19 by randomly assigning healthy people to receive SARS-CoV-2
or a placebo and seeing who develops COVID-19.” The real-world version is also simple: no.

Ethics: The Part of Science That Prevents Us From Becoming Cartoon Villains

Clinical research is governed by ethics principles that exist for a reason: history taught us what happens when researchers treat humans like lab equipment.
Modern ethics focuses on informed consent, minimizing harm, and something called clinical equipoise
genuine uncertainty within the expert community about which option is better.

If you already know that exposure to a pathogen can cause harm, you do not have equipoise about assigning people to the “get infected” arm.
You have a moral obligation to avoid preventable risk, not to “balance” it for scientific aesthetics.

But What About Human Challenge Trials?

Here’s where satire meets reality: human challenge trials are a real research method. In a challenge study, carefully selected volunteers may be exposed
to a pathogen under controlled conditions to answer specific questionsusually when risks are low, rescue treatments exist, and oversight is intense.
COVID-19 challenge trials have been debated heavily, with arguments on both sides about risk, consent, and scientific value.

Notice what challenge studies are not: a casual internet “Gotcha!” experiment designed to prove a basic fact that is already supported by multiple
lines of evidence. Challenge trials are narrow, purpose-built, ethically scrutinized, and still controversial.
They are not the scientific equivalent of “Fine, if you’re so sure, lick the subway pole.”

What We Actually Did: RCTs for Treatments and Vaccines (Like Normal People)

During the pandemic, researchers ran many randomized trialsjust not the kind imagined by the “RCT-or-it-didn’t-happen” crowd.
The question wasn’t “Is the virus real?” The urgent questions were:
What prevents severe disease? What reduces hospitalization and death?
What keeps health systems from becoming a Jenga tower in an earthquake?

Vaccines: Randomized, Placebo-Controlled, and Extremely Un-Internet

The pivotal COVID-19 vaccine trials were large, randomized, and placebo-controlled (especially early on, when no authorized vaccines existed).
Participants were randomly assigned to receive vaccine or placebo, and researchers compared outcomes like symptomatic infection and severe disease.
This is classic RCT territory: testing an intervention intended to reduce risk.

Over time, as effective vaccines became available, the ethics of placebo arms changed. In many settings, you don’t compare a new vaccine to “nothing”
if doing so would deny participants a proven protective option. Instead, trials may compare to an existing vaccine or use other designs.
That shift isn’t “hiding the truth.” It’s applying ethical standards to avoid withholding beneficial care.

Treatments: Randomized Trials Under Pressure

Treatments also saw randomized trials, including adaptive designs that allow modifications as evidence emerges.
These trials asked practical questions: does an antiviral shorten illness? Does it reduce progression to severe disease?
Can a therapy help hospitalized patients recover faster?

This is where RCTs shinecomparing interventions under controlled conditions so clinicians aren’t guessing based on vibes, wishful thinking,
or the most confident person on a livestream.

How Do We Know SARS-CoV-2 Causes COVID-19 Without That One Specific RCT?

First, a reality check: COVID-19 is defined as the disease caused by the virus SARS-CoV-2.
That relationship is established through converging evidenceclinical observation, virology, pathology, epidemiology,
and consistent patterns across settings and time.

If you’re thinking, “That still sounds like a lot of science words,” fair. Here’s the short version:
when you repeatedly find the same virus in people with the same disease, watch the disease spread along with the virus,
measure immune responses specific to that virus, and see risk drop when interventions block that virus,
you don’t need an “infection-or-placebo” RCT to conclude causation. You need a functioning scientific method.

Different Questions Need Different Evidence

• “Does a vaccine reduce risk?” Great RCT question.
• “Does a drug improve outcomes?” Also great RCT question.
• “Does a virus cause a disease?” Usually answered through virology + clinical + epidemiologic evidence, not by randomizing infection.
• “How well do vaccines work in real life?” Often answered with observational effectiveness studies, because people have lives and ethics exist.

In other words: if you demand one kind of study for every kind of question, you’re not being rigorous.
You’re being monogamous with methodology. And science is not impressed by methodological clinginess.

The Satirical “Trial Protocol” You Didn’t Know You Needed

Let’s indulge the satire for a moment, purely to show how absurd the demand becomes when you spell it out.
Imagine a proposed RCT titled:
“A Double-Blind, Placebo-Controlled Trial of Receiving a Virus, For Science.”

Inclusion Criteria

• Must be human (sorry, goldfish).
• Must enjoy paperwork (consent forms will be approximately the length of a Russian novel).
• Must understand that “randomized” does not mean “fate has chosen you as the main character.”

Exclusion Criteria

• Anyone with a pulse (because risks exist).
• Anyone without a pulse (because also risks exist).
• Anyone who thinks “placebo virus” is a real thing you can order online.

The institutional review board (IRB) response arrives within minutes:
“Absolutely not. Please stop emailing. We have blocked your address.”

Satire aside, that’s the point: the reason you don’t see “RCTs of the virus” is not because scientists are afraid of the truth.
It’s because science is conducted inside the boundaries of ethics, feasibility, and common sense.

What’s Actually Worth Randomizing Now

If you want to be genuinely “science-based” today, the more interesting questions look like this:
Which vaccine schedules best protect high-risk groups? What outcomes should regulators prioritize for updated vaccines?
When are placebo-controlled trials ethical or useful, and when do they become an obstacle course built out of delays?
How should trials be designed when variants evolve and population immunity changes?

These aren’t hypothetical. Regulators, researchers, and clinicians continue debating trial design and evidence standardsespecially
when deciding what counts as meaningful benefit in lower-risk populations and how to balance speed, rigor, and ethics.
That’s not a sign of weakness. It’s what responsible science looks like when it’s awake.

Conclusion: The RCT Is Not a Universal Remote Control

RCTs are a cornerstone of modern medicine because they help isolate the effects of interventions.
But the pandemic also taught a broader lesson: the best evidence often comes from multiple methods working together.
You don’t use a single study design as a loyalty test for reality.

If someone demands “randomized controlled clinical trials of SARS-CoV-2” as proof the virus causes COVID-19,
they’re not being extra scientific. They’re confusing the tool with the job.
And if we’re going to be strict about standards, let’s apply the right standards to the right questions
not just the loudest standards to the widest possible set of topics.

Experiences From the “Prove It With an RCT” Era (A 500-Word Reality Check)

One of the strangest pandemic-era experiences wasn’t the sudden popularity of sourdough starters or the way everyone became an amateur aerosol engineer.
It was watching methodology become a personality trait. People didn’t just disagree about conclusionsthey argued about which kinds of evidence
were allowed to exist in the first place.

Clinicians described the whiplash of trying to practice medicine while the evidence was still forming. Early on, hospitals were under pressure,
patients were scared, and teams were making decisions with incomplete datathen adjusting fast as randomized trials and better observational studies arrived.
Many frontline staff remember the shift from “we’re trying everything” to “we’re trying the things that actually show benefit,” a transition powered by
real clinical trials and hard-earned standardization.

Researchers tell a parallel story: the messy middle of science. Some trials were well-designed and informative; others were small, redundant, or poorly coordinated.
The experience sparked conversations about platform trials, adaptive designs, and how to collaborate across institutions without duplicating effort.
In the background, ethics committees weighed risk in real timetrying to protect participants while recognizing that delaying good evidence also has costs.

For everyday people, the experience was often psychological as much as medical. Many remember the confusion of seeing confident claims on social media
that didn’t match what their doctors said, or what public health agencies recommended. The phrase “Do your own research” became a slogansometimes a genuine
invitation to learn, other times a shortcut to cherry-picking. People who tried to read studies learned a humbling truth:
a single paper can be persuasive, but a body of evidence is harder to manipulate.

Teachers and parents watched “science literacy” become suddenly practical. Kids asked why masks mattered, why vaccines took time, why rules changed.
The best explanations weren’t perfect, but they were honest: science updates when it learns. That can feel unsettlinglike the ground moving under your feet
but it’s also how we get closer to reality instead of clinging to the first loud idea that shows up.

And then there was the cultural experience of the RCT as a rhetorical weapon. Some people demanded randomized trials for questions where randomization made no sense,
while ignoring randomized trials when results were inconvenient. It was a reminder that “trust the science” and “show me the RCT” can both be used sincerelyor
used as costumes. The lasting lesson isn’t that one method rules them all. It’s that good thinking requires matching the method to the question,
respecting ethics, and staying curious even when certainty would feel more comfortable.